Edward T Morgan

Plain English
Researchers studied how the liver breaks down compounds found in kratom, a plant used for medicinal purposes. They discovered that the way the body processes kratom varies significantly depending on the specific components of the plant, with different metabolites (or products of metabolism) being created. This work is important because it helps to understand both the potential therapeutic effects and toxic risks associated with kratom, which can inform safer use. Who this helps: This benefits patients using kratom for treatment and healthcare providers who need to understand its effects.

Plain English
This study examined how a substance produced by gut bacteria, called delta-valerobetaine, is converted in the body into a new compound named homocarnitine. Researchers found that this conversion occurs in the liver and can be influenced by certain nutrients, such as iron and vitamin C. The findings suggest that homocarnitine might play a significant role in obesity and metabolic issues by affecting how the body processes fats. Who this helps: This information benefits patients dealing with obesity and metabolic disorders, as well as doctors treating these conditions.

Plain English
This study looked at how to better assess the confidence we have in identifying metabolites (the small molecules involved in metabolism) in scientific research. The researchers introduced a new method called "identification probability," which calculates the likelihood that a measured compound matches a known one, based on a database of compounds. They showed that this method can improve the consistency and automation of metabolite identification, making it easier to apply across different types of scientific equipment. Who this helps: This benefits researchers and scientists working in metabolomics and related fields.

Plain English
This study looked at how exposure to second-hand smoke from traditional and electronic cigarettes affects the blood of infants and children. Researchers found that a substance called menthol glucuronide, linked to the flavor menthol, was present along with cotinine (a marker of tobacco exposure), and certain metabolic pathways were changed in these children. Specifically, the study discovered connections between menthol and oxidative stress markers that could be related to lung diseases. Who this helps: This information benefits parents, healthcare providers, and policymakers focusing on reducing children's exposure to harmful substances from smoking.

Plain English
This study created a new database called PharmMet DB that contains information about how 1,114 different medications are broken down in the human liver. Researchers found that a large majority of the drugs—89%—produced at least one metabolite (a substance formed when the drug is processed) that was not previously predicted, highlighting the complexity of drug metabolism. This information is important because it can help doctors understand how drugs work in real patients, leading to better safety and effectiveness in treatments. Who this helps: This primarily benefits patients and doctors involved in precise medication management.

Plain English
This study looked at improving a method for freezing thick brain tissue samples to get clearer images of cells and structures in their natural state. Researchers found that using certain cryoprotectants allowed them to successfully freeze mouse brain tissue up to 100 microns thick while preserving its functionality. This is important because it helps scientists better understand the brain's structure and function, which can lead to advancements in medical research and treatment. Who this helps: This benefits researchers and scientists studying brain health and disease.

Plain English
This study looked at how inflammation affects the liver’s ability to process drugs. Researchers found that when inflammation occurs, certain enzymes that metabolize drugs are often downregulated, leading to reduced metabolism of these drugs. For instance, inflammatory signals can decrease the activity of specific enzymes, which varies across different diseases and can significantly impact how individuals respond to medications. This is important because understanding this process can help improve drug development and personalize treatment for patients. Who this helps: This helps patients who require medication, particularly those with inflammatory conditions.

Plain English
This study looked at how scientists can better measure the confidence that a certain chemical compound has been correctly identified in metabolomics, which is the study of small molecules in cells. The researchers proposed a new method called "identification probability," where confidence is calculated as a simple fraction (1/N), with N being the number of matching compounds in a reference library. They believe this method can improve the accuracy and reliability of identifying compounds in various scientific studies by making the process easier and more consistent. Who this helps: This benefits researchers and scientists working in metabolomics and related fields.

Plain English
This article celebrates the 50th anniversary of a scientific journal focused on understanding how drugs are processed in the body. Over the years, significant advancements were made in areas like drug metabolism, with a major leap in knowledge about drug-related enzymes and transporters, which are now crucial for safe drug development. The insights from five former editors highlight the challenges and rewards of managing the journal, aiming to inspire future leaders in scientific publishing. Who this helps: This benefits researchers and authors looking to understand drug interactions and improve drug design.

Plain English
The study looked at how special human liver cells can produce and identify various chemicals created when drugs and other substances are processed in the body. Researchers used these modified cells to efficiently generate metabolites from 36 different chemicals and identified specific enzymes responsible for their breakdown. They found that this method allows for faster and more accurate profiling of chemical exposures in humans, which is important for tracking drug use and environmental toxins. Who this helps: This benefits researchers and doctors studying drug interactions and disease effects on patients.

Plain English
This study explored a new method to identify harmful chemicals (xenobiotic metabolites) that enter our bodies from the environment. The researchers developed an enzyme-based technique that improves the accuracy of identifying these chemicals in samples from both mice and humans. They found that their method could help reliably detect specific metabolites, enhancing our understanding of how environmental factors contribute to diseases. Who this helps: This benefits researchers and healthcare providers tracking environmental impacts on health.

Plain English
This study looked at how nitric oxide (NO), a molecule associated with inflammation and found in cigarette smoke, affects the enzyme CYP2A6, which is important for breaking down nicotine and other substances in the body. Researchers found that when human liver cells were treated with NO, the amount of CYP2A6 was reduced to about 40% of its normal level within four hours. This decrease was linked to a process called ubiquitination, which marks the enzyme for degradation, and it doesn't require the enzyme to be active for this to occur. Who this helps: This benefits patients who use nicotine products, as it sheds light on how smoking might affect drug metabolism in the body.

Plain English
Researchers studied how nitric oxide (NO) affects the degradation of a liver enzyme called CYP2B6, specifically looking at how certain changes in its structure might make it disappear more quickly. They found that specific tyrosine sites on the enzyme are critical for its breakdown, with mutations at positions Y317 and Y380 making the enzyme more resistant to degradation. This is important because understanding this process could help develop treatments that protect the enzyme during liver inflammation, which is commonly linked to drug metabolism and liver injuries. Who this helps: This helps patients who rely on medications processed by the CYP2B6 enzyme, particularly those with liver inflammation.

Plain English
This study examined how nitric oxide (NO) affects certain liver enzymes called cytochrome P450 enzymes, which are important for breaking down drugs in the body during inflammatory diseases. It was found that NO can reduce the activity and levels of these enzymes, likely by interfering with their function; for example, when nitric oxide levels rise, the activity of these enzymes drops significantly. Understanding this process matters because it could improve drug metabolism and effectiveness in patients with inflammation-related health issues. Who this helps: This helps patients with inflammatory diseases and their doctors in managing medication effectively.

Plain English
This study looked at how a non-lethal malaria infection in mice affects the body’s ability to process and clear certain drugs. The researchers found that at the peak of infection, the clearance of four common drugs was reduced by 60-70%, indicating that malaria can significantly change how the body handles medications. This is important because it suggests that malaria infections can make it harder for the body to respond properly to anti-malarial drugs and other medications, which could impact treatment outcomes. Who this helps: This helps patients with malaria by highlighting the need for careful monitoring and possible adjustments in drug dosing during infection.

Plain English
This research examined how various factors like pregnancy, gut bacteria, inflammation, infections, and fasting affect how our bodies process medications. For example, studies in mice showed that pregnancy significantly influences drug-metabolizing enzymes, while gut bacteria can impact drug processing by affecting certain metabolites. This understanding is crucial as it can help improve medication effectiveness and safety for different people under various conditions. Who this helps: Patients needing personalized medication adjustments based on health conditions.

Plain English
This study looked at how nitric oxide (NO) affects a specific enzyme called CYP2J2, which helps process certain substances in the body, including some medications. The researchers found that when they introduced NO to liver cells, the amount of CYP2J2 decreased quickly, with levels dropping significantly over time; however, the gene for CYP2J2 was not turned off, and stopping the NO treatment allowed the enzyme's activity to return. This matters because understanding how NO regulates this enzyme could impact how drugs are metabolized in the body, potentially affecting patient treatment plans. Who this helps: Patients taking medications that are metabolized by the CYP2J2 enzyme.

Plain English
Researchers at the 21st International Symposium on Microsomes and Drug Oxidations explored how different factors like genetics, gut bacteria, and diseases affect how our bodies handle medications. They shared that understanding these influences could lead to personalized medicine that better suits individual patients, potentially reducing drug side effects and improving effectiveness. For example, they looked into how these factors change drug absorption and metabolism. Who this helps: This helps patients who need tailored treatments for better health outcomes.

Plain English
This study looked at how a molecule called nitric oxide (NO) affects the levels of a liver enzyme named CYP2B6, which is important for drug metabolism. Researchers found that when cells were exposed to nitric oxide, the levels of this enzyme dropped significantly within just 3 hours, even though the gene that makes the enzyme wasn't affected. Specifically, CYP2B6 activity decreased, indicating that NO leads to the breakdown of the enzyme through a process called ubiquitination, which targets proteins for destruction. Who this helps: This research benefits doctors by enhancing their understanding of how certain medications might be metabolized differently in patients with inflammation or other conditions that affect nitric oxide levels.

Plain English
This study looked at how nitric oxide affects a protein called CYP51A1, which is important for cholesterol production in humans. Researchers found that when they treated liver cells with nitric oxide, the levels of this protein dropped quickly, with about a 50% decrease after treatment, indicating that nitric oxide selectively reduces its presence. This matters because understanding how nitric oxide regulates this protein could lead to better insights into cholesterol management and related health conditions. Who this helps: This helps patients with cholesterol issues and healthcare providers looking for targeted treatments.

Plain English
This study looked at the role of a protein called EphB2 in liver damage caused by malaria in mice. The researchers found that mice lacking the EphB2 protein were protected from liver fibrosis, even when the level of malaria infection was similar to normal mice. Specifically, these EphB2-deficient mice had less inflammation and fewer immune cells that contribute to liver damage. This is important because it uncovers a potential target for treating liver fibrosis in malaria and possibly other liver diseases. Who this helps: This helps patients with liver diseases, especially those affected by malaria.

Plain English
This study focused on a liver enzyme called CYP2C22, which helps break down retinoic acid, a compound important for many bodily functions. Researchers found that the levels of CYP2C22 in liver cells were reduced significantly (to less than 25% of normal levels) when exposed to certain compounds, particularly nitric oxide (NO) and a signaling molecule called interleukin-1 (IL-1), indicating that these substances can rapidly lower the enzyme's presence. This finding highlights a new way the body regulates this enzyme, which could have implications for understanding liver metabolism and diseases related to retinoic acid. Who this helps: This helps doctors and researchers who study liver diseases and metabolism.

Plain English
This study looked at how the Schistosoma mansoni parasite affects liver enzymes that break down drugs in mice. It found that after 45 days of infection, most liver enzymes involved in drug metabolism were significantly reduced, with specific genes showing 5 to 10 times lower expression. This matters because it highlights how infections can impact drug effectiveness and metabolism, which may affect treatment for people infected with this parasite. Who this helps: This helps doctors and researchers understand how to treat patients with schistosomiasis more effectively.

Plain English
This study looked at how an infection in mice affects the liver's ability to process drugs and bile acids. The researchers found that several important transporters in the liver were significantly decreased during the infection, which could disrupt bile acid balance and lead to liver issues. Specifically, levels of key transporters dropped by significant amounts, such as the transporter for bile acids which decreased by up to 50%. Who this helps: This research can benefit doctors treating patients with liver conditions related to infections.

Plain English
Researchers studied how two specific genes, Cyp4a10 and Cyp4a14, affect the body's response to an infection caused by the bacteria Citrobacter rodentium in mice. They found that mice without these genes had weaker responses to the infection, including changes in their spleen weight and levels of proteins associated with inflammation. This is important because it helps us understand how our bodies react to certain infections and could lead to new treatments for inflammatory diseases. Who this helps: This benefits patients suffering from inflammatory diseases and their doctors.

Plain English
In this study, researchers examined how a new treatment called XPro1595, which targets a protein involved in inflammation, affects liver enzymes that help break down drugs during a gastrointestinal infection. They found that giving this treatment every three days kept certain liver enzymes active, while a single dose wasn't very effective. This matters because it shows that XPro1595 can change how the body processes drugs during illness, potentially leading to drug interactions that could affect treatment outcomes. Who this helps: Patients who take medications while dealing with infections.

Plain English
This study examines how inflammation related to cancer affects the body's ability to process certain drugs, specifically those metabolized by a type of enzyme called cytochrome P450 (CYP). Researchers found that inflammation can reduce the effectiveness of these enzymes, which may interfere with new cancer treatments that help boost the immune system. This is important because understanding these interactions can improve treatment effectiveness and help patients avoid adverse effects from multiple medications. Who this helps: This helps patients undergoing cancer treatment and their doctors.

Plain English
This study examined how a specific protein called CYP2B in liver cells breaks down when influenced by a molecule called nitric oxide (NO) and a cytokine known as interleukin-1 (IL-1). The researchers found that when liver cells are treated with IL-1, the breakdown of CYP2B proteins happens faster, especially when another protein, LMP2, is involved. Specifically, IL-1 increased LMP2 levels within 6-12 hours, and blocking LMP2 reduced the degradation of CYP2B, highlighting the important role of LMP2 in this process. Who this helps: This research benefits patients with liver conditions by improving understanding of liver protein breakdown.

Plain English
This research studied how an infection with the bacteria Citrobacter rodentium affects certain liver enzymes in mice that lack a functioning immune system. The researchers found that immune-deficient mice showed a six-fold increase in bacterial movement to the liver compared to normal mice and displayed different patterns in the expression of liver enzymes related to drug metabolism. This matters because understanding how infections influence liver enzyme activity could help in managing treatments during infections. Who this helps: This helps doctors and researchers working to improve treatments for infections, particularly in patients with weakened immune systems.

Plain English
The study investigated how certain proteins (cytokines) affect liver function during an infection in mice caused by a specific pathogen. The researchers found that a protein called tumor necrosis factor-alpha (TNF-α) was responsible for lowering levels of two liver enzymes, CYP3A11 and CYP3A25, during infection, while another protein called interleukin-1 and a type of liver cell (Kupffer cells) did not have this effect. This is important because understanding how these proteins influence liver enzyme activity can inform treatment strategies for infections that affect liver function. Who this helps: This helps patients with liver conditions and their doctors.

Plain English
This study looked at how a specific bacteria, Citrobacter rodentium, affects liver enzymes called cytochrome P450s in genetically modified mice that lack certain immune molecules (interleukin-6 and interferon-gamma). Researchers found that while most cytochrome P450 enzymes were affected similarly in all mouse types, some changes in specific enzymes were influenced by interleukin-6, while interferon-gamma also played a role in regulating other enzymes. Understanding these effects is important because it helps researchers learn how infections can alter liver function, which is crucial for drug metabolism. Who this helps: This information benefits doctors and researchers focusing on liver health and infection-related treatments.

Plain English
This study looked at how different proteasome inhibitors, which are used in research, affect liver cells from humans. The researchers found that while bortezomib effectively stopped the production of certain substances in these cells, other drugs like MG132 and epoxomicin did not work well because they were quickly broken down by liver enzymes. This is important because it shows that bortezomib is a better choice for studying liver function in certain conditions. Who this helps: This helps researchers working with liver cells and developing treatments for liver-related diseases.

Plain English
This study looked at how an intestinal infection caused by a bacteria called Citrobacter rodentium affects liver enzymes in mice. It found that during the infection, certain liver enzymes (CYP4A and CYP2D9) were decreased or increased significantly; for example, CYP2D9 levels rose 8 to 9 times. These changes in liver enzyme levels were linked to the severity of inflammation and infection, peaking around 7 to 10 days after infection. Who this helps: This research benefits doctors and patients by improving understanding of how infections can affect liver function.

Plain English
This study looked at how a specific type of inflammation in the intestines affects liver enzymes called cytochrome P450 in mice. Researchers found that when they induced inflammation using a chemical, the liver produced fewer of these enzymes, and that some changes were linked to a protein called TLR4 while others were not. Understanding these differences is important because it helps explain how different causes of inflammation can affect liver function. Who this helps: This helps doctors and researchers who treat patients with inflammatory bowel disease and related liver issues.

Plain English
This study looked at how certain genes related to liver enzymes, known as Fmo genes, respond to inflammation in different mouse models. The researchers found that the Fmo3 gene was most affected during infections with *Citrobacter rodentium*, with a significant decrease, and that the down-regulation of Fmo1, Fmo3, and Fmo5 also occurred in response to another inflammation trigger, lipopolysaccharide (LPS). Understanding these changes is important because they could influence how the liver processes drugs and toxins during inflammation, which is critical for patient safety and treatment effectiveness. Who this helps: Patients who are treated for infections and inflammatory conditions.

Plain English
The study examined how a protein called CYP3A1 in liver cells is affected by inflammation. Researchers found that when liver cells were treated with an inflammatory substance (IL-1beta), CYP3A1 protein levels dropped to 40% of normal within 6 hours, while its genetic material (mRNA) levels remained unchanged for the first 24 hours. This decline in protein levels was linked to nitric oxide and a process called proteasomal degradation, but after 24 hours, the down-regulation happened through different mechanisms that did not rely on these factors. Who this helps: This research is important for doctors and patients who rely on medications processed by the liver, especially during inflammatory conditions.

Plain English
This study looked at how infections and inflammation affect the body's ability to process drugs, focusing on specific enzymes called cytochrome P450s. The researchers found that when a person has an infection or inflammation, these enzymes work less effectively, which can change how drugs are metabolized. This understanding is important because it can help doctors adjust medication dosages based on a patient’s health status, improving treatment outcomes. Who this helps: This research benefits doctors and patients who are being treated for infections or inflammatory diseases.

Plain English
This study focused on how inflammatory agents, specifically a cytokine called interleukin-1beta (IL-1), affect the levels of a liver enzyme known as cytochrome P450 2B (CYP2B) in rat liver cells. Researchers found that treatment with IL-1 reduced CYP2B protein levels by more than 60% within 6 hours, and this reduction was linked to the presence of nitric oxide (NO). This discovery is important because understanding how inflammation affects liver function could help in developing better treatments for liver-related diseases. Who this helps: This research benefits patients with liver diseases and their doctors.

Plain English
This study looked at how nitric oxide affects certain enzymes called cytochromes P450, particularly CYP2B6, during inflammation in human liver cells. Researchers found that when cells were exposed to inflammation, CYP2B6 levels dropped to only 9% of normal for its mRNA and 19% for the protein. Adding nitric oxide reduced CYP2B6 protein to 30% of normal, but didn’t significantly alter its mRNA levels, suggesting nitric oxide works differently on these levels. Who this helps: This research benefits doctors and patients who rely on liver enzymes for drug metabolism, as understanding these mechanisms can improve treatments for inflammatory diseases.

Plain English
This research focused on how infections, inflammation, and cancer affect the body's ability to process and use medications. The findings showed that inflammation, especially from tumors, can change the levels of important enzymes and transporters that break down drugs, which may lead to severe side effects from treatments like chemotherapy. It's important because understanding these changes helps doctors use medications more safely and effectively for patients facing various health issues. Who this helps: Patients with infections, chronic inflammation, and cancer.

Plain English
This study looked at the role of a liver enzyme called SCD1 in worsening inflammation and colitis, a type of intestinal disorder. Researchers found that when SCD1 levels dropped in mice with colitis, it led to higher inflammation markers and made the disease worse. Specifically, mice lacking SCD1 were more affected than normal mice, and feeding them oleic acid helped reduce the severity of their condition. This is important because it suggests that targeting SCD1 could be a new way to treat inflammatory diseases like colitis. Who this helps: This helps patients with inflammatory bowel diseases, including ulcerative colitis.

Plain English
This study examined the effects of a compound called 4-chlorophenylacetate (4-CPA) on mice that are sensitive to estrogen and prone to developing breast tumors. The researchers found that 4-CPA successfully prevented the formation of tumors in these mice, indicating its potential as a new treatment for estrogen-sensitive breast cancer. This discovery is significant because it offers a new option without the side effects found in current therapies. Who this helps: This helps patients with estrogen-sensitive breast cancer.

Plain English
This study looked at how certain enzymes in rat liver cells, called CYP4Fs, process inflammatory substances like leukotriene B4 (LTB4) and how they are affected by various signaling molecules. Researchers found that pro-inflammatory signals increased the production of these enzymes, while the anti-inflammatory signal IL-10 reduced it. Specifically, they noted a significant response in CYP4F5 levels when liver cells faced high amounts of LTB4, indicating that these enzymes don't manage LTB4 levels well during inflammation. Who this helps: This research benefits doctors and researchers focusing on liver inflammation and related diseases.

Plain English
This study looked at how certain inflammatory proteins affect the levels of specific liver enzymes (cytochromes P450) that help break down drugs in the human body. Researchers found that a protein called interleukin-6 reduced the levels of several liver enzymes, while other inflammatory factors had varying impacts—some enzymes like CYP2B6 only reacted to specific proteins. These findings highlight that inflammation can change how our bodies process medications, which is important for treating patients with infections or inflammatory conditions. Who this helps: This helps doctors and patients, particularly those undergoing treatment for infections or inflammatory diseases.

Plain English
This study looked at how inflammation and infection affect specific enzymes in the liver and kidneys of mice that help process drugs. Researchers found that certain liver enzymes (UGT1A1, 1A9, and 2B5) decreased in activity during inflammation or infection, while others (UGT1A2 and 1A6) remained stable. These findings matter because they could impact how drugs are processed during illnesses, potentially affecting treatment effectiveness and safety. Who this helps: This helps doctors and patients by providing insights into how infections might alter drug metabolism.

Plain English
This study looked at how a common gut infection, caused by the bacterium Citrobacter rodentium, affects liver and kidney genes in two types of mice: normal mice and those with a specific immune receptor missing. They found that in normal mice, certain liver genes related to drug processing were greatly reduced, with some down to less than 4% of normal levels, while a few were actually increased. These changes are linked to the immune response triggered by the infection, which is important because they can affect how well the liver processes medications during illness. Who this helps: This research benefits patients by improving understanding of how infections can impact medication metabolism.

Plain English
This study looked at how inflammation affects the activity of enzymes that help break down medications in the liver. Researchers found that inflammation reduces the function of cytochrome P450 enzymes, which can lead to higher levels of drugs in the bloodstream and more side effects. Understanding this process is important because it can help doctors manage medication dosages better, especially during times of illness. Who this helps: This helps patients who are taking medications during inflammatory conditions.

Plain English
This study looked at how inflammation, triggered by a substance called LPS, affects specific liver proteins involved in drug metabolism known as cytochrome P450 enzymes in genetically modified mice. Researchers found that levels of many of these enzymes dropped significantly after LPS treatment, but the decrease happened regardless of the presence of two particular receptors, PPARalpha and PXR. For instance, mRNA levels of several cytochrome P450 enzymes decreased, while levels of inflammation markers like TNFalpha increased sharply, indicating that the body's response to inflammation can suppress these important enzymes without the influence of those receptors. Who this helps: This research benefits doctors and researchers working on liver health and inflammation-related conditions.